TMC EXAM B (RESPIRATORY) | 2025 LATEST UPDATED| 140
COMPLETE QUESTIONS AND ANSWERS | 100% RATED
CORRECT | 100% VERFIED | ALREADY GRADED A+|GET A+
A patient with a PBW of 55 kg (121 lb) is receiving VC, A/C ventilation. Ventilator
settings and blood gas analysis results are:
FIO2 0.70
Mandatory rate 14
VT 350 mL
PEEP 5 cm H2O
pH 7.35
PaCO2 35 mm Hg
PaO2 40 mm Hg
HCO3- 19 mEq/L
BE -6 mEq/L
,SO2 (calc) 74%
A respiratory therapist should recommend
A.
changing to SIMV mode.
B.
increasing to 10 cm H2O PEEP.
C.
changing to 5 cm H2O CPAP.
D.
increasing to 400 mL VT. - (answer)B. √
increasing to 10 cm H2O PEEP.
EXPLANATIONS
,(h) A. Changing to SIMV will not treat the hypoxemia. It may also cause a
decrease in minute ventilation and adverse changes in the acid-base status.
(c) B. The increase in PEEP will increase FRC, decrease the intrapulmonary shunt,
and address the hypoxemia.
(h) C. Changing to CPAP may decrease minute ventilation causing adverse changes
in the acid-base status.
(u) D. Increasing the tidal volume will further decrease the PaCO2. It will not
significantly improve oxygenation.
When instructing a patient on the administration of umeclidinium/vilanterol
(Anoro Ellipta), which of the following is most important to emphasize?
A.
Gargle immediately after use.
, B.
Inhale slowly with a breath hold.
C.
Breathe in fast and deep.
D.
Shake medication vigorously before use. - (answer)C.
Breathe in fast and deep.
EXPLANATIONS:
(u) A. Umeclidinium/vilanterol (Anoro Ellipta) is not an inhaled steroid and, thus,
does not require gargling after use.
(u) B. Umeclidinium/vilanterol (Anoro Ellipta) is a DPI that requires rapid
inhalation.
(c) C. Breathing in fast and deep is the proper method of administration for
umeclidinium/vilanterol (Anoro Ellipta).
COMPLETE QUESTIONS AND ANSWERS | 100% RATED
CORRECT | 100% VERFIED | ALREADY GRADED A+|GET A+
A patient with a PBW of 55 kg (121 lb) is receiving VC, A/C ventilation. Ventilator
settings and blood gas analysis results are:
FIO2 0.70
Mandatory rate 14
VT 350 mL
PEEP 5 cm H2O
pH 7.35
PaCO2 35 mm Hg
PaO2 40 mm Hg
HCO3- 19 mEq/L
BE -6 mEq/L
,SO2 (calc) 74%
A respiratory therapist should recommend
A.
changing to SIMV mode.
B.
increasing to 10 cm H2O PEEP.
C.
changing to 5 cm H2O CPAP.
D.
increasing to 400 mL VT. - (answer)B. √
increasing to 10 cm H2O PEEP.
EXPLANATIONS
,(h) A. Changing to SIMV will not treat the hypoxemia. It may also cause a
decrease in minute ventilation and adverse changes in the acid-base status.
(c) B. The increase in PEEP will increase FRC, decrease the intrapulmonary shunt,
and address the hypoxemia.
(h) C. Changing to CPAP may decrease minute ventilation causing adverse changes
in the acid-base status.
(u) D. Increasing the tidal volume will further decrease the PaCO2. It will not
significantly improve oxygenation.
When instructing a patient on the administration of umeclidinium/vilanterol
(Anoro Ellipta), which of the following is most important to emphasize?
A.
Gargle immediately after use.
, B.
Inhale slowly with a breath hold.
C.
Breathe in fast and deep.
D.
Shake medication vigorously before use. - (answer)C.
Breathe in fast and deep.
EXPLANATIONS:
(u) A. Umeclidinium/vilanterol (Anoro Ellipta) is not an inhaled steroid and, thus,
does not require gargling after use.
(u) B. Umeclidinium/vilanterol (Anoro Ellipta) is a DPI that requires rapid
inhalation.
(c) C. Breathing in fast and deep is the proper method of administration for
umeclidinium/vilanterol (Anoro Ellipta).
